Plan Group Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Plan Group Financial's GILD Position: Q3 2026 in Review
Plan Group Financial increased its Gilead Sciences (GILD) stake by 25% in Q3 2026, buying an estimated $93.6K and bringing the position to 3,384 shares worth $530K. The position accounts for 0.1% of the portfolio, ranked #111.
Plan Group Financial first reported a position in GILD in Q1 2026 and has held it in 3 quarters since. 2,354 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Plan Group Financial held 3,384 shares of Gilead Sciences worth $530K as of Q3 2026.
- Plan Group Financial bought 667 Gilead Sciences shares in Q3 2026, an estimated $93.6K.
- Gilead Sciences made up 0.1% of Plan Group Financial's portfolio in Q3 2026, its #111 holding.
- Plan Group Financial first reported a position in Gilead Sciences in Q1 2026 and has held it in 3 quarters since.
- 2,354 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Plan Group Financial's 13F filing for Q3 2026, filed 22 Oct 2026.